HMS Holdings Corp (NASDAQ:HMSY) COO Douglas M. Williams sold 87,414 shares of the stock in a transaction on Friday, August 9th. The stock was sold at an average price of $38.14, for a total value of $3,333,969.96. Following the transaction, the chief operating officer now directly owns 99,983 shares in the company, valued at approximately $3,813,351.62. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of NASDAQ HMSY opened at $39.16 on Thursday. The company has a quick ratio of 6.72, a current ratio of 6.72 and a debt-to-equity ratio of 0.32. The stock has a market cap of $3.48 billion, a PE ratio of 46.62, a P/E/G ratio of 3.18 and a beta of 1.39. HMS Holdings Corp has a 1-year low of $26.22 and a 1-year high of $39.96. The stock’s fifty day moving average is $34.90.
HMS (NASDAQ:HMSY) last issued its quarterly earnings data on Friday, August 2nd. The business services provider reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.18. The firm had revenue of $168.20 million during the quarter, compared to analysts’ expectations of $158.25 million. HMS had a return on equity of 15.22% and a net margin of 16.08%. The firm’s quarterly revenue was up 14.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.25 EPS. Analysts predict that HMS Holdings Corp will post 1.08 EPS for the current year.
A number of equities analysts have recently issued reports on HMSY shares. Credit Suisse Group increased their price target on HMS from $40.00 to $45.00 and gave the stock an “outperform” rating in a research report on Monday, August 5th. Guggenheim started coverage on HMS in a research report on Wednesday, April 17th. They set a “buy” rating on the stock. Zacks Investment Research downgraded HMS from a “buy” rating to a “hold” rating in a research report on Friday, May 10th. Chardan Capital raised HMS from a “neutral” rating to a “buy” rating and increased their price target for the stock from $37.00 to $41.00 in a research report on Monday, July 1st. Finally, Leerink Swann started coverage on HMS in a research report on Monday, August 5th. They set an “outperform” rating and a $50.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. HMS has a consensus rating of “Buy” and an average price target of $42.10.
HMS Company Profile
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.